View Item 

Show simple item record

Distinct pattern of TP53 mutations in human immunodeficiency virusâ related head and neck squamous cell carcinoma
dc.contributor.authorGleber‐netto, Frederico O.
dc.contributor.authorZhao, Mei
dc.contributor.authorTrivedi, Sanchit
dc.contributor.authorWang, Jiping
dc.contributor.authorJasser, Samar
dc.contributor.authorMcDowell, Christina
dc.contributor.authorKadara, Humam
dc.contributor.authorZhang, Jiexin
dc.contributor.authorWang, Jing
dc.contributor.authorWilliam, William N.
dc.contributor.authorLee, J. Jack
dc.contributor.authorNguyen, Minh Ly
dc.contributor.authorPai, Sara I.
dc.contributor.authorWalline, Heather M.
dc.contributor.authorShin, Dong M.
dc.contributor.authorFerris, Robert L.
dc.contributor.authorCarey, Thomas E.
dc.contributor.authorMyers, Jeffrey N.
dc.contributor.authorPickering, Curtis R.
dc.date.accessioned2018-02-05T16:48:54Z
dc.date.available2019-03-01T21:00:18Zen
dc.date.issued2018-01-01
dc.identifier.citationGleber‐netto, Frederico O. ; Zhao, Mei; Trivedi, Sanchit; Wang, Jiping; Jasser, Samar; McDowell, Christina; Kadara, Humam; Zhang, Jiexin; Wang, Jing; William, William N.; Lee, J. Jack; Nguyen, Minh Ly; Pai, Sara I.; Walline, Heather M.; Shin, Dong M.; Ferris, Robert L.; Carey, Thomas E.; Myers, Jeffrey N.; Pickering, Curtis R. (2018). "Distinct pattern of TP53 mutations in human immunodeficiency virusâ related head and neck squamous cell carcinoma." Cancer 124(1): 84-94.
dc.identifier.issn0008-543X
dc.identifier.issn1097-0142
dc.identifier.urihttps://hdl.handle.net/2027.42/142251
dc.publisherWiley Periodicals, Inc.
dc.subject.otherhuman papillomavirus (HPV)
dc.subject.othermutation
dc.subject.otherhuman immunodeficiency virus (HIV)
dc.subject.otherhead and neck cancer
dc.subject.otherTP53 gene
dc.titleDistinct pattern of TP53 mutations in human immunodeficiency virusâ related head and neck squamous cell carcinoma
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbsecondlevelPublic Health
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/142251/1/cncr31063.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/142251/2/cncr31063_am.pdf
dc.identifier.doi10.1002/cncr.31063
dc.identifier.sourceCancer
dc.identifier.citedreferenceHayes DN, Van Waes C, Seiwert TY. Genetic landscape of human papillomavirusâ associated head and neck cancer and comparison to tobaccoâ related tumors. J Clin Oncol. 2015; 33: 3227 â 3234.
dc.identifier.citedreferenceEngsig FN, Gerstoft J, Kronborg G, et al. Head and neck cancer in HIV patients and their parents: a Danish cohort study. Clin Epidemiol. 2011; 3: 217 â 227.
dc.identifier.citedreferenceD’Souza G, Carey TE, William WN, et al. Epidemiology of head and neck squamous cell cancer among HIVâ infected patients. J Acquir Immune Defic Syndr. 2014; 65: 603 â 610.
dc.identifier.citedreferenceHelleberg M, Gerstoft J, Afzal S, et al. Risk of cancer among HIVâ infected individuals compared to the background population: impact of smoking and HIV. AIDS. 2014; 28: 1499 â 1508.
dc.identifier.citedreferenceSingh B, Balwally AN, Shaha AR, Rosenfeld RM, Harâ El G, Lucente FE. Upper aerodigestive tract squamous cell carcinoma. The human immunodeficiency virus connection. Arch Otolaryngol Head Neck Surg. 1996; 122: 639 â 643.
dc.identifier.citedreferencePowles T, Powles J, Nelson M, et al. Head and neck cancer in patients with human immunodeficiency virusâ 1 infection: incidence, outcome and association with Epsteinâ Barr virus. J Laryngol Otol. 2004; 118: 207 â 212.
dc.identifier.citedreferenceWalline HM, Carey TE, Goudsmit CM, et al. Highâ risk HPV, biomarkers, and outcome in matched cohorts of head and neck cancer patients positive and negative for HIV. Mol Cancer Res. 2016; 15: 179 â 188.
dc.identifier.citedreferenceMourad WF, Hu KS, Shasha D, et al. Longâ term outcome of seropositive HIV patients with head and neck squamous cell carcinoma treated with radiation therapy and chemotherapy. Anticancer Res. 2013; 33: 5511 â 5516.
dc.identifier.citedreferenceMcLemore MS, Haigentz M, Smith RV, et al. Head and neck squamous cell carcinomas in HIVâ positive patients: a preliminary investigation of viral associations. Head Neck Pathol. 2010; 4: 97 â 105.
dc.identifier.citedreferenceAgrawal N, Frederick MJ, Pickering CR, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 2011; 333: 1154 â 1157.
dc.identifier.citedreferenceStransky N, Egloff AM, Tward AD, et al. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011; 333: 1157 â 1160.
dc.identifier.citedreferenceLawrence MS, Sougnez C, Lichtenstein L, et al. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015; 517: 576 â 582.
dc.identifier.citedreferenceD’Souza G, Kreimer AR, Viscidi R, et al. Caseâ control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007; 356: 1944 â 1956.
dc.identifier.citedreferencePoeta ML, Manola J, Goldwasser MA, et al. TP53 mutations and survival in squamousâ cell carcinoma of the head and neck. N Engl J Med. 2007; 357: 2552 â 2561.
dc.identifier.citedreferenceNeskey DM, Osman AA, Ow TJ, et al. Evolutionary action score of TP53 identifies highâ risk mutations associated with decreased survival and increased distant metastases in head and neck cancer. Cancer Res. 2015; 75: 1527 â 1536.
dc.identifier.citedreferenceBaylor College of Medicine. EAp53 server. http://mammoth.bcm.tmc.edu/cgiâ bin/panos/EAp53.cgi. Accessed June 1, 2016.
dc.identifier.citedreferencePicard A, Badoual C, Hourseau M, et al. HPV prevalence in HIV patients with head and neck squamous cell carcinoma. AIDS. 2016; 30: 1257 â 1266.
dc.identifier.citedreferenceMarur S, D’Souza G, Westra WH, Forastiere AA. HPVâ associated head and neck cancer: a virusâ related cancer epidemic. Lancet Oncol. 2010; 11: 781 â 789.
dc.identifier.citedreferenceSouza RP, Gimenes F, De Abreu AL, et al. Differences in the mutation of the p53 gene in exons 6 and 7 in cervical samples from HIVâ and HPVâ infected women. Infect Agent Cancer. 2013; 8: 38.
dc.identifier.citedreferenceZhou G, Wang J, Zhao M, et al. Gainâ ofâ function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activation. Mol Cell. 2014; 54: 960 â 974.
dc.identifier.citedreferencePfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P. Tobacco smoke carcinogens, DNA damage and p53 mutations in smokingâ associated cancers. Oncogene. 2002; 21: 7435 â 7451.
dc.identifier.citedreferencePickering CR, Zhang J, Neskey DM, et al. Squamous cell carcinoma of the oral tongue in young nonâ smokers is genomically similar to tumors in older smokers. Clin Cancer Res. 2014; 20: 3842 â 3848.
dc.identifier.citedreferenceBrickman C, Palefsky JM. Cancer in the HIVâ infected host: epidemiology and pathogenesis in the antiretroviral era. Curr HIV/AIDS Rep. 2015; 12: 388 â 396.
dc.identifier.citedreferenceMangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature. 2003; 424: 99 â 103.
dc.identifier.citedreferenceHarris RS, Bishop KN, Sheehy AM, et al. DNA deamination mediates innate immunity to retroviral infection. Cell. 2003; 113: 803 â 809.
dc.identifier.citedreferenceBishop KN, Holmes RK, Sheehy AM, Malim MH. APOBECâ mediated editing of viral RNA. Science. 2004; 305: 645.
dc.identifier.citedreferenceMatsumoto Y, Marusawa H, Kinoshita K, et al. Helicobacter pylori infection triggers aberrant expression of activationâ induced cytidine deaminase in gastric epithelium. Nat Med. 2007; 13: 470 â 476.
dc.identifier.citedreferenceAlexandrov LB, Nikâ Zainal S, Wedge DC, et al. Signatures of mutational processes in human cancer. Nature. 2013; 500: 415 â 421.
dc.identifier.citedreferenceBurns MB, Lackey L, Carpenter MA, et al. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature. 2013; 494: 366 â 370.
dc.identifier.citedreferenceLindley RA. The importance of codon context for understanding the Igâ like somatic hypermutation strandâ biased patterns in TP53 mutations in breast cancer. Cancer Genet. 2013; 206: 222 â 226.
dc.identifier.citedreferenceHenderson S, Chakravarthy A, Su X, Boshoff C, Fenton TR. APOBECâ mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirusâ driven tumor development. Cell Rep. 2014; 7: 1833 â 1841.
dc.identifier.citedreferenceIzumi T, Io K, Matsui M, et al. HIVâ 1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication. Proc Natl Acad Sci U S A. 2010; 107: 20798 â 20803.
dc.identifier.citedreferenceSato Y, Tsurumi T. Genome guardian p53 and viral infections. Rev Med Virol. 2013; 23: 213 â 220.
dc.identifier.citedreferenceVerma S, Ali A, Arora S, Banerjea AC. Inhibition of βâ TrcP dependent ubiquitination of p53 by HIVâ 1 Vpu promotes p53 mediated apoptosis in human T cells. Blood. 2011; 117: 6600 â 6608.
dc.identifier.citedreferenceGreenway AL, McPhee DA, Allen K, et al. Human immunodeficiency virus type 1 Nef binds to tumor suppressor p53 and protects cells against p53â mediated apoptosis. J Virol. 2002; 76: 2692 â 2702.
dc.identifier.citedreferenceKim RH, Yochim JM, Kang MK, Shin KH, Christensen R, Park NH. HIVâ 1 Tat enhances replicative potential of human oral keratinocytes harboring HPVâ 16 genome. Int J Oncol. 2008; 33: 777 â 782.
dc.identifier.citedreferenceQureshi MN, Barr CE, Hewlitt I, et al. Detection of HIV in oral mucosal cells. Oral Dis. 1997; 3 ( suppl 1 ): S73 â S78.
dc.identifier.citedreferenceMoore JS, Rahemtulla F, Kent LW, et al. Oral epithelial cells are susceptible to cellâ free and cellâ associated HIVâ 1 infection in vitro. Virology. 2003; 313: 343 â 353.
dc.identifier.citedreferenceGrulich AE, Van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a metaâ analysis. Lancet. 2007; 370: 59 â 67.
dc.identifier.citedreferencePatel P, Hanson DL, Sullivan PS, Novak RM, Moorman AC. Incidence of types of cancer among HIVâ infected persons compared with the general population in the United States, 1992â 2003. Ann Intern Med. 2008; 148: 728 â 736.
dc.identifier.citedreferenceLin CS, Lin C, Weng SF, Lin SW, Lin YS. Cancer survival in patients with HIV/AIDS in the era of highly active antiretroviral therapy in Taiwan: a populationâ based cohort study. Cancer Epidemiol. 2013; 37: 719 â 724.
dc.identifier.citedreferenceGritz ER, Vidrine DJ, Lazev AB, Amick BC, Arduino RC. Smoking behavior in a lowâ income multiethnic HIV/AIDS population. Nicotine Tob Res. 2004; 6: 71 â 77.
dc.identifier.citedreferenceMdodo R, Frazier EL, Dube SR, et al. Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: crossâ sectional surveys. Ann Intern Med. 2015; 162: 335 â 344.
dc.identifier.citedreferenceStrickler HD, Burk RD, Fazzari M, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virusâ positive women. J Natl Cancer Inst. 2005; 97: 577 â 586.
dc.identifier.citedreferenceXi LF, Koutsky LA, Castle PE, et al. Relationship between cigarette smoking and human papilloma virus types 16 and 18 DNA load. Cancer Epidemiol Biomarkers Prev. 2009; 18: 3490 â 3496.
dc.identifier.citedreferenceSchabath MB, Villa LL, Lazcanoâ Ponce E, Salmeron J, Quiterio M, Giuliano AR. Smoking and human papillomavirus (HPV) infection in the HPV in Men (HIM) study. Cancer Epidemiol Biomarkers Prev. 2012; 21: 102 â 110.
dc.identifier.citedreferenceMesri EA, Feitelson MA, Munger K. Human viral oncogenesis: a cancer hallmarks analysis. Cell Host Microbe. 2014; 15: 266 â 282.
dc.identifier.citedreferenceDe Martel C, Shiels MS, Franceschi S, et al. Cancers attributable to infections among adults with HIV in the United States. AIDS. 2015; 29: 2173 â 2181.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
cncr31063.pdf
Size:
2.107MB
Format:
PDF
View/Open
Name:
cncr31063_am.pdf
Size:
663.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.